Mobile

Study of efficacy and safety of secukinumab compared to ustekinumab in subjects with plaque psoriasis

Mise à jour : Il y a 5 ans
Référence : EUCTR2015-002898-37

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To demonstrate the superiority of secukinumab compared to ustekinumab in subjects with moderate to severe plaque psoriasis with respect to both PASI 90 and IGA mod 2011 0/1 response at Week 12

Critère d'inclusion

  • Moderate to severe chronic plaque-type psoriasis

Liens